KRTAP7-1

Across TCGA pan-cancer cohorts, KRTAP7-1 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated KRTAP7-1 data layer compared with 14 for mass-spec protein.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher KRTAP7-1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated KRTAP7-1 expression acts as an unfavorable survival marker.

KIRC are the cancer types where KRTAP7-1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Median	All	0.167	0.655	.038	12	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

KRTAP7-1–KIRC (OS)

Open the KIRC breakdown →